A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program

Por Tong, Kenneth, Nicandro, Jean Paul, Shringarpure, Reshma, Chuang, Emil, Chang, Lin
Publicado em 2013

Alosetron use in clinical practice: significant improvement in irritable bowel syndrome symptoms evaluated using the US Food and Drug Administration composite endpoint

Por Lacy, Brian E., Nicandro, Jean Paul, Chuang, Emil, Earnest, David L.
Publicado no Therap Adv Gastroenterol (2018)

Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases

Por Lee, Jessica Y., Wasinger, Valerie C., Yau, Yunki Y., Chuang, Emil, Yajnik, Vijay, Leong, Rupert WL.
Publicado no Proteomes (2018)

Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohn’s Disease, and Ulcerative Colitis Patients

Por Plevy, Scott, Silverberg, Mark S., Lockton, Steve, Stockfisch, Tom, Croner, Lisa, Stachelski, Jordan, Brown, Michelle, Triggs, Cheryl, Chuang, Emil, Princen, Fred, Singh, Sharat
Publicado em 2013

APD125, a Selective Serotonin 5-HT(2A) Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia

Por Rosenberg, Russell, Seiden, David J., Hull, Steven G., Erman, Milton, Schwartz, Howard, Anderson, Christen, Prosser, Warren, Shanahan, William, Sanchez, Matilde, Chuang, Emil, Roth, Thomas
Publicado em 2008

Antibodies to Infliximab Are Associated with Lower Infliximab Levels and Increased Likelihood of Surgery in Pediatric IBD

Por Zitomersky, Naamah L., Atkinson, Benjamin J., Fournier, Kerri, Mitchell, Paul D., Stern, Julia Bender, Butler, Michael C., Ashworth, Lori, Hauenstein, Scott, Heiner, Linda, Chuang, Emil, Singh, Sharat, Bousvaros, Athos
Publicado no Inflamm Bowel Dis (2015)

Combination of Genetic and Quantitative Serological Immune Markers are Associated with Complicated Crohn’s Disease Behavior

Por Lichtenstein, Gary R., Targan, Stephan R., Dubinsky, Marla C., Rotter, Jerome I., Barken, Derren M., Princen, Fred, Carroll, Susan, Brown, Michelle, Stachelski, Jordan, Chuang, Emil, Landers, Carol J., Stempak, Joanne M., Singh, Sharat, Silverberg, Mark S.
Publicado em 2011

Challenges in IBD Research: Environmental Triggers

Por Ho, Shuk-Mei, Lewis, James D, Mayer, Emeran A, Bernstein, Charles N, Plevy, Scott E, Chuang, Emil, Rappaport, Stephen M, Croitoru, Kenneth, Korzenik, Joshua R, Krischer, Jeffrey, Hyams, Jeffrey S, Judson, Richard, Kellis, Manolis, Jerrett, Michael, Miller, Gary W, Grant, Melanie L, Shtraizent, Nataly, Honig, Gerard, Hurtado-Lorenzo, Andrés, Wu, Gary D
Publicado no Inflamm Bowel Dis (2019)